Faculty Bibliography

BACKGROUND CONTEXT: The comparison of various frailty indices and their ability to predict complications after ASD surgery has not been investigated. PURPOSE: Assess whether certain frailty indices have predictability of complication rates following ASD surgery. STUDY DESIGN/SETTING: Retrospective. PATIENT SAMPLE: A total of 689 ASD patients. OUTCOME MEASURES: Complication rates, clinical outcomes, cost-utility.
METHOD(S): Operative ASD patients with baseline (BL) and 2-year (2Y) data were included. Four frailty indices were used for comparison: Passias et al modified ASD frailty index (mFI), Miller et al ASD frailty index (FI-ASD), the ACS-NSQIP 5-Factor frailty index (ACS-FI5), and the FRAIL Scale (PMID:29792992). Patients were stratified into not frail (NF), frail (F) and severely frail (SF). Associations of the indices with EBL, op time, complications, hospital-acquired conditions (HAC: UTI, DVT/PE, SSI), reoperations, SICU stay, and LOS were compared using one-way ANOVA, logistic and linear regression analyses.
RESULT(S): There were 421 ASD patients included (Age: 60.4, BMI: 28.0, CCI: 1.9). Total cohort complication rates: 71% any comp, 27% major (68% were surgical, 32% medical), 35% minor, 25% intraoperative, 18% mechanical, 22% underwent reoperation. Upon presentation, severely frail patients were much more likely to present with a severe ODI (OR: 16, [7.2-29.8]). All four indices significantly correlated with intraop details and comps. During hospital stay, all four indices correlated to SICU time and total LOS. Only FRAIL Scale correlated with SICU admission rate (OR: 1.2, [1.03-8.8]), while no index was predictive of comps prior to discharge (all p>.05). ASD-FI had the strongest correlation with periop comps, including HACs (OR: 1.2, [1.1-6.3]), any (OR: 1.2, [1.02-7.3]) and major comps (OR: 1.5, [1.1-4.7]). When assessing 2Y comps, logistic regression analysis demonstrated correlation between ASD-FI, mFI, and FRAIL Scale indices and any comps, major comps and reoperation. However, mFI was the only correlate for all 2Y comps (any, major, minor, mech, reop), along with highest OR for predicting mechanical comps (OR: 1.6, [1.3-1.9]). Clinically, ASD-FI SF group had the greatest improvement (ODI,SRS-Total), while mFI SF had lowest rates of improvement. Given their higher complication rates, this translated to higher cost per QALY by 2 years for SF pts when stratified by mFI (p<.001).
CONCLUSION(S): Frailty imposes a significant burden on adult spinal deformity patients from the moment of presentation through cost-utility at two years. Assessing frailty by different measures demonstrated meaningful differences in complications and outcomes. These findings highlight the impact of frailty stratification during surgical planning to effectively assess the risk of patients undergoing corrective surgery. FDA DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices or drugs.
Copyright

BACKGROUND CONTEXT: Adult spinal deformity (ASD) refers to multiple types of spinal deformity. This study used a prospective multicenter database of patients with "complex" surgical ASD to derive a data-driven classification of different deformity patterns, and assessed if such patterns have distinct clinical outcomes. PURPOSE: Use an AI-based unsupervised approach to identify patterns of ASD. STUDY DESIGN/SETTING: Retrospective analysis of a multi-center prospective database. PATIENT SAMPLE: A total of 286 patients with complex ASD who underwent surgical correction. OUTCOME MEASURES: Operative decision-making and 30-day adverse events.
METHOD(S): Complex surgical ASD included severe deformity, surgical complexity or advanced age with a multilevel fusion. An unsupervised cluster analysis that allowed for 10% outliers was used to identify different patterns of deformity. Perioperative outcomes of these clusters were then compared using ANOVA, Kustal-Wallis, and Chi-Squared analyses as indicated, with p-value < 0.05 considered significant.
RESULT(S): The Hyper-Kyphosis (Hyper TK, n = 31) group had a mean thoracic kyphosis of 82.6+/-17.6degree, lumbar hyperextension (PI-LL: -20.4+/-14.7degree) and relatively straight coronal curvatures. Hyper-Kyphosis patients were the youngest (mean age 48+/-20 years) and had the lowest disability (mean ODI 32.9+/-17.1) and pain scores (median NRS back 6 IQR 3 to 8, median NRS leg 1 IQR 0 to 4). The Severe Coronal (Coronal, n = 91) group had a mean thoracic Cobb of 44.7+/-17.8degree and a mean thoraco-lumbar Cobb of 57.9+/-16.5degree with preserved global sagittal alignment. Coronal patients had moderate disability (mean ODI 33.5+/-18.8), functional impairment (PCD: 34.4+/-12.3) and pain scores (median NRS back 7 IQR 5 to 8, median NRS leg 4 IQR 0 to 7). The Severe Sagittal (Sev. Sag. n=79) group had a severe spino-pelvic mismatch (42.9+/-12.9degree) and global sagittal deformity (24.3+/-7.9degree). Sev Sag had higher BMIs (28.9+/-5.9), high levels of disability (mean ODI 49.3+/-15.6) and low appearance scores (2.3+/-0.7). Finally, the Moderate Sagittal (Mod. Sag. n=85) group had moderate deformities without distinctive radiographic characteristics, a mean age of 68.8+/-7.8degree, the highest PROMIS pain interference sub-scores (65.2+/-5.8), high levels of disability (mean ODI 47.6+/-15.3) and back pain (NRS back 7 IQR 6 to 9), and poor overall quality of life (mean SRS total 2.8+/-0.6). Thirty-day adverse events were equivalent. Hyper TK and Coronal patients had the longest constructs, but fusion to the pelvis was most common in Mod Sag (89.4%) and Sev Sag (97.5%) deformities. Coronal patients had more osteotomies per case (median 11 IQR 6.5 to 14), longer OR times, and more 30-day implant-related complications (5.5%). Sev Sag and Hyper TK patients were more likely to require a 3-column osteotomy (43% and 32.3%, respectively). Sev Sag deformities were more likely to require interbody implants (29.1%) and operative wound debridement (7.6%). Hyper TK patients had shorter hospital stays.
CONCLUSION(S): AI methodologies identified 4 distinct patient clusters within a large population of surgically treated ASD patients. Each ASD cluster presented with 1) a unique spinal deformity pattern, 2) reported distinct pathognomonic health deficits, 3) received consistent surgical treatment across 11 centers, and 4) had characteristic perioperative complications and hospital stays. FDA DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices or drugs.
Copyright

BACKGROUND CONTEXT: Despite multiple reports showing favorable long-term functional outcomes following adult spinal deformity (ASD) correction, it is still unclear which patient factors may impact the sustainability of these outcomes. PURPOSE: To assess the sustainability of functional gains following ASD correction and determine predictors for postoperative loss of patient functionality. STUDY DESIGN/SETTING: Retrospective cohort. PATIENT SAMPLE: A total of 689 ASD patients. OUTCOME MEASURES: Sustained clinical benefit, Oswestry Disability Index (ODI), reoperation, mechanical failure, proximal junctional failure (PJF) METHODS: ASD patients with baseline (BL) and three-year (3Y) follow-up data were considered for analysis. Only patients who met the definition of sustained clinical benefit (SCB) at one-year (1Y) were included: 1)Passias et al's threshold for ODI (ODI<31.3), 2) did not develop PJF, and 3) did not have a reoperation for a mechanical failure. Patient groups were created by those who met SCB at 3Y, and those who did not. SCB outcomes were also reported at five-years (5Y) postoperatively. Means comparison tests assessed differences in patient groups. Factors predicting SCB were identified using adjusted regression and conditional inference tree (CIT) analysis.
RESULT(S): A total of 157 patients met inclusion criteria and had SCB at 1Y. Patient breakdown for SCB was 75.0% at 3Y. Gender (78% vs 81%), BMI (25.5 vs 26.4), levels fused (10.6 vs 10.5), operative time (345 vs 362 min), and surgical invasiveness were similar between groups, all P>.05. Following surgery, patient groups were similarly aligned to Lafage et al's age-adjusted PT, PI-LL, and SVA, all P>.05. Regression and CIT analysis adjusting for BL deformity determined that patients who met SCB at 3Y were 95.4% less likely to have an ASD-mFI score > 11 (.046[.005-.420], p=0.006), 73.1% less likely to be older than 55 years at DOS (.269[.091-.798], p=.018), 69.4% less likely to have a CCI score > 0(.306[.116-.811], p=.017), and 86.9% less likely to have a BL EQ5D score <.723 (.131[.029-.585], p=.008). Adjusted for patients without follow-up, sustained clinical benefit at 5Y was 57.9%. Predictors of SCB from 3Y to 5Y included age, CCI and EQ5D, all P <.05.
CONCLUSION(S): Sustained clinical benefit was maintainable for 75.0% of the operative ASD cohort at 3Y. Similarly, a 57.9% maintenance rate of sustained clinical benefit at 5Y reflects the longevity of ASD correction. Independent predictors of sustained clinical benefit included age, frailty, comorbidities and the patient health state. FDA DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices or drugs.
Copyright

BACKGROUND CONTEXT: While past research has shown racial disparities exist in the outcomes and utilization of spine surgery, those studies were often performed on nondisease-specific national databases, which may capture different patient populations and complication rates compared to prospective multicenter databases. PURPOSE: Purpose: 1) Assess racial disparities for enrollment in two prospective multicenter databases (ASD-

BACKGROUND CONTEXT: Current radiographic thresholds have shown inconsistent correlation with clinical outcomes. However, it has not been determined at what point in presenting deformity does sagittal correction tremendously improve clinical outcomes following cervical deformity surgery. PURPOSE: Define baseline thresholds in cervical parameters that, when exceeded, benefit dramatically from surgical correction to achieve ideal clinical outcomes. STUDY DESIGN/SETTING: Retrospective. PATIENT SAMPLE: A total of 290 ACD patients. OUTCOME MEASURES: Clinical outcomes, radiographic alignment.
METHOD(S): CD patients with baseline (BL) and 2-year (2Y) data included. Parameters assessed: C2 slope (C2S), C2-C7 Lordosis, C2-C7 SVA (cSVA), T1 Slope (T1S), TS-CL.
Outcome(s): Virket al Good Clinical Outcome (GCO): [Meeting 2 of 3: 1) an NDI>20 or meeting MCID, 2) mJOA >=14), 3) an NRS-Neck<=5 or improved by 2 or more points from baseline]. Binary logistic regression assessed each parameter to determine if correction was more likely needed to achieve GCO. Conditional inference tree (CIT) run machine learning analysis generated baseline thresholds for each parameter, above which, correction was necessary to achieve GCO.
RESULT(S): Included: 105 CD patients. There were 57 (54%) of patients achieving GCO by 2Y. Correction was necessitated when baseline C2S was above 20degree (OR: 6.8, [1.6-28.9]; p=.01) and when baseline C2-C7 Lordosis was below 10degree (OR: 16, [2.4-107.5]; p=.004). Patients presenting with a cSVA above 20 mm more often achieved clinical success when corrected (74.2% vs 0.0%, p<.001). A baseline T1 slope above 23degree was 16 times more likely to reach GCO with correction than those below this threshold (p=.005). TS-CL more likely required correction to reach GCO when above 26degree at baseline (OR: 7.0, [1.7-29.1]; p=.007). When assessing patients above both the cSVA and C2S threshold versus the remaining cohort, these patients more likely met GCO when corrected in either parameter (OR: 22.5, [3.3-152.0]; p=.001).
CONCLUSION(S): Our study highlighted the importance of correction and the threshold at which it dramatically impacts clinical success. These new thresholds delineate patients obtaining superior benefit for sagittal correction and may better increase the utility gained from surgical intervention for cervical deformity. FDA DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices or drugs.
Copyright

BACKGROUND CONTEXT: While reimbursement is centered on 90-day outcomes, some patients persevere through these short-term, transient complications and manage to still achieve optimal, long-term outcomes. PURPOSE: Assess whether achieving optimal alignment suffering similar perioperative complications compared to suboptimally-aligned peers are inhibited from reaching long-term clinical success and better cost-utility. STUDY DESIGN/SETTING: Retrospective cohort study of a prospective adult spinal deformity (ASD) database. PATIENT SAMPLE: A total of 1,541 patients. OUTCOME MEASURES: Cost-per-QALY, radiographic realignment, clinical outcomes.
METHOD(S): Operative ASD pts with 2Y data were included. Optimal radiographic outcome was defined by SRS-Schwab low deformity in PI-LL, matched in T1PA and being aligned in PI-based PT at 6 weeks. After stratifying pts based on meeting optimal outcome, multivariate analysis controlling for baseline demographics was used to determine significance for complications and hospital-acquired conditions (HACs; DVT/PE, UTI, deep/superficial infection). Calculated Cost per QALY for each time point by 2Y.
RESULT(S): There were 917 ASD pts included. Regarding approach, 69% posterior approach, 31% combined. Groups: 131 were "optimal" (O) and 786 were "not optimal" (NO). Means comparison tests revealed significant differences in age, BMI, but not gender or frailty. The NO group had fewer osteotomies and a lower Invasiveness Index. Analysis of perioperative complications showed that the O group suffered equivocal perioperative complications (58.0% vs 52.2% in the NO group; p=.173) and rates of HACs (9.0% vs. 8.9%, p=.810). Analysis of long-term complications showed that patients in the NO group suffered more major neurological (p=.015) and major mechanical complications (p=.025), and more reoperations (28.7% vs 19.9%; p=.037). When controlling for baseline deformity, age, BMI and frailty, Optimal Outcome patients more often met Best Clinical Outcome (21.5% vs. 11.7%, p=.002). Cost-utility adjusted analysis with determined no difference in the two groups by 6 weeks and 6 months. However, the O group generated significantly better cost-utility by one year, which maintained lower Costs per QALY (p=.005) at two years in favor of the O group.
CONCLUSION(S): Despite incurring equivocal perioperative complications, patients who met our optimal outcome criteria experienced significantly less mechanical complications and reoperations by 2 years, leading to a better long-term cost-utility overall. Accordingly, a higher, transient perioperative complication profile should not preclude surgical correction and future policy efforts should place more consideration on the long-term for outcome measures in adult spinal deformity surgery. FDA DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices or drugs.
Copyright

BACKGROUND CONTEXT: The impact of neuromuscular disorders such as multiple sclerosis (MS) on outcomes following long segment (4+ level) fusion is underreported. PURPOSE: To identify the impact of MS on two-year (2Y) postoperative complications and revisions following 4 level fusion for ASD. STUDY DESIGN/SETTING: Retrospective cohort. PATIENT SAMPLE: Patients undergoing 4+ level fusion for ASD were identified from the New York State Statewide Planning and Research Cooperative System. OUTCOME MEASURES: Two-year postoperative complications and reoperations.
METHOD(S): Patients undergoing 4-level fusion for ASD were identified from the New York Statewide Planning and Research Cooperative System. Patients with a baseline diagnosis of MS were also identified. Patients with infectious/traumatic/neoplastic indications were excluded. Subjects were 1:1 propensity score-matched (MS to no-MS) by age, sex, and race and compared for rates of 2-year postoperative complications and reoperations. Logistic regression models were utilized to determine risk factors for adverse outcomes at 2 years.
RESULT(S): A total of 86 patients were included (n=43 per group). Age (50.1 vs 50.1 years, p=0.225), sex and race were comparable between groups. MS pts incurred higher charges for their surgical visit ($125,906 vs $84,006, p=0.007) with similar LOS (8.1 vs 5.3 days, p>0.05). MS patients experienced comparable rates of overall medical complications (30.1% vs 25.6%) and surgical complications (34.9% vs 30.2%) all p>0.05. MS pts had similar rates of 2-year revisions (16.3% vs 9.3%, p=0.333). MS was not associated with medical, surgical or overall complications or revisions at minimum 2-year follow-up.
CONCLUSION(S): Patients with MS experienced similar postoperative course compared to those without MS following 4-level fusion for ASD. This data supports the findings of multiple previously published case series' that long segment fusions for ASD can be performed relatively safely in patients with MS. FDA DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices or drugs.
Copyright

BACKGROUND CONTEXT: Previous studies have demonstrated that preoperative rehabilitation (prehab) may be beneficial in adult cervical deformity surgery. Though protocols vary widely, general overlap exists in terms of inclusion of mental and physical modalities in order to optimize patient outcomes. However, there remains a paucity of literature in regards to assessing outcomes in a controlled setting. PURPOSE: To assess the effects of prehabilitation on peri- and postoperative outcomes in adult cervical deformity surgery. STUDY DESIGN/SETTING: Retrospective review of prospective CD database. PATIENT SAMPLE: A total of 290 CD patients. OUTCOME MEASURES: Peri- and postoperative complication rates; medication usage; HRQLs.
METHOD(S): Operative CD patients 18yrs with complete pre-(BL) and 2-year(2Y) postop radiographic/HRQL data were stratified by enrollment in prehabilitation protocols beginning in 2019, consisting of physical therapy, nutritional counseling and/or psychological counseling. Patients were stratified as having underwent prehabilitation (Prehab+), versus those who did not (Prehab-). Differences in demographics, clinical outcomes, radiographic alignment targets, perioperative factors and complication rates were assessed via means comparison analysis. Costs were calculated using PearlDiver database estimates from Medicare pay-scales. QALY was calculated via NDI mapped to SF6D using validated methods.
RESULT(S): A total of 115 patients were included (56.37+/-8.90 years, 38% female, 29.84+/-6.19 kg/m2). Of these patients, 57 (49.6%) were classified as Prehab+. At baseline, groups were comparable in age, gender, BMI, CCI and frailty. In terms of BL HRQLs, Prehab+ significantly lower mJOA scores (p=.047), though were equivalent in NDI and EQ5D scores (both p>.05). Baseline opioid usage was comparable prior to prehab enrollment (p=.093). Surgically, Prehab+ were able to undergo longer procedures (p=.017) with equivalent EBL (p=.627), and shorter SICU stay (p.05) and QALYs gained by 2Y (.43 vs.40, p>.05).
CONCLUSION(S): This study demonstrates that introducing prehabilitation protocols in adult cervical deformity surgery may aid in improving patient physiological status, enabling them to undergo longer surgeries with lessened risk of peri- and postoperative complications. Though cost-effectiveness of such programs should be further assessed, prehabilitation should be considered for eligible patients to assist in optimizing recovery and reducing complications or reoperations. FDA DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices or drugs.
Copyright

BACKGROUND CONTEXT: Numerous studies have reported the interplay between spinal deformity and pelvis compensatory mechanisms, but little data exist evaluating the contribution of lower extremity compensation (LE) to maintain upright posture. We hypothesis that hip, knee and ankle compensation is proportional to the severity of the spinal deformity and varies by demographics. PURPOSE: Evaluate the association between spinal alignment and lower limbs compensation. STUDY DESIGN/SETTING: Multicenter, prospective cohort. PATIENT SAMPLE: This study included 288 patients treated for complex adult spinal deformity (ASD) with full body images available. OUTCOME MEASURES: Pelvic retroversion (PT), hip extension (SFA), knee flexion (KA), ankle dorsiflexion (AA), pelvic translation (P.Shift) and patient reported outcomes (ODI, PROMIS and SRS-22).
METHOD(S): Surgical ASD patients were enrolled into a prospective study based on three criteria: deformity severity (PI-LL>25degree, TPA>30degree, SVA>15cm, TCobb>70degree or TLCobb>50degree), procedure complexity (>12 levels fused, 3CO or ACR) and/or age (>65 and >7 levels fused). Associations between lower extremity compensation (hip extension, knee flexion, and ankle dorsiflexion) and the magnitude of spinal deformity, patient demographics, patient frailty, and patient-reported outcomes (ODI, SRS, PROMIS-CAT) were assessed via regressions and partial correlations.
RESULT(S): A total of 288/329 patients met inclusion criteria (60+/-15yo, 70.5% female), had moderate to severe spinal deformity (PI-LL:15+/-24, TPA:24+/-14, SVA:65+/-69mm, lumbar Cobb:34+/-24), and reported high pain (PROMIS pain interference; PI=62.7+/-7.8) and reduced physical function (PROMIS physical function; PF=35.6+/-7.6). Lower extremity compensation included pelvic retroversion (PT:24.1+/- 11.8), hip extension (SFA: 203+/-10.5), knee flexion (KA:5.5+/- 9.6), ankle dorsiflexion (AA: 5.3+/-4.5), and posterior pelvic translation (P.Shift: 30+/-51mm). Overall, lower extremity compensation increased with age (all p <0.001), BMI and frailty (all p <0.001, except SFA). For a similar PT, women had greater hip extension than men (SFA: 206 vs 200, p <0.001), with less KA (3.6 vs. 10.1, p <0.001), AA, and P.Shift. Lower extremity compensation increased with PI (r=0.2-0.45, p <0.001), TPA (r=0.5-0.9, p <0.001) and correlated with PROMS (ODI:0.26 - 0.37, PROMIS PF: -0.28 - -0.39, SRS Acti.: -0.20 - -0.33). When controlling for deformity severity and PI, most associations between lower limbs compensation and PROMS were lost. However, P.Shift and SFA remained weakly correlated with physical scores (ODI and PROMIS PF).
CONCLUSION(S): The recruitment of LE compensation is overall proportional to the severity of adult spinal deformity, with different patterns observed between men and women. Patients achieved similar PT by recruiting different patterns of LE compensation. Hip extension and posterior pelvic translation are independently associated with impairment in patient-reported outcomes. FDA DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices or drugs.
Copyright

BACKGROUND CONTEXT: Bone Morphogenetic Protein-2 (BMP-2) has not shown superior benefit in terms of overall cost-effectiveness after implementation during adult spinal deformity (ASD) surgery. However, it remains to be shown whether certain discrete populations do obtain cost-utility from use of BMP-2. PURPOSE: Generate a score to determine usage of BMP-2 and correlate with rates of pseudarthrosis. STUDY DESIGN/SETTING: Retrospective cohort study of a single-center ASD database. PATIENT SAMPLE: A total of 689 ASD patients. OUTCOME MEASURES: Cost utility, pseudarthrosis.
METHOD(S): ASD patients with BL and 2-year(2Y) data included. BMP-2 kit size and cost: small - 4.2 mg ($21,800), medium - 8.4 mg ($23,667), large - 12 mg ($25,617). Published methods converted ODI to SF-6D. QALYs utilized a 3% discount rate for residual decline. Cost was calculated using the PearlDiver database and assessed for Complications and Comorbidities and Major Complications and Comorbidities according to CMS.gov definitions. Binary logistic regression analyses determined significant predictors for development of pseudarthrosis. Established weights were generated for predictive variables via back-step logistic regression for a risk score to predict development of pseudarthrosis. Risk score was then validated via Receiver Operating Characteristic (ROC) curve method analysis. Categories via conditional inference tree (CIT) analysis-derived thresholds were tested for cost-utility of BMP-2 usage. Marginalized means for utility gained and Cost per QALY were calculated within each risk score category, controlling for age, history of prior fusion, and baseline deformity and disability.
RESULT(S): Included: 387 ASD patients. Of 387, 64% received BMP-2 (1% small, 4% medium, 59% large). There were 17 (4.4%) of patients that developed pseudarthrosis by two years, 9 (2.3%) of which underwent reoperation. BMP-2 use, regardless of kit size, did not significantly lower pseudarthrosis rates overall (OR: 0.4, [0.2-1.04]). A predictive risk score for development of pseudarthrosis was formed by the following preoperative variables: age, frailty, history of diabetes, osteoporosis, depression, ASA grade, and baseline L4-S1 and T1PA. Via ROC method, this predictive risk score generated an AUC of 0.87. Following CIT machine learning, thresholds for the BMP Risk Score were derived: >5 No Risk (NoR), 3-5 Low Risk (LowR), 2-3 Moderate Risk (ModR), and <2 High Risk (HighR). The rates of pseudarthrosis for each category were: NoR - 0%; LowR - 1.6%; ModR - 9.3%; HighR - 24.3%. When assessing BMP-2 use and its cost-utility within each group, patients receiving BMP-2 had similar QALYs to those that did not receive BMP-2 (0.163 vs 0.171, p=.65). BMP-2 usage had significantly worse cost-utility in both NoR and LowR cohorts (both p<.05). In ModR patients, BMP-2 usage had equivocal cost-utility ($680,532.35 vs $580,380.21, p=.14). In the HighR cohort, the cost-utility difference narrowed even further (BMP-2 use: $743,155.21 vs $719,628.79, p=.82).
CONCLUSION(S): Our study shows BMP-2 has equivocal cost-utility within those at moderate and high risk for developing pseudarthrosis within two years following spinal deformity correction. The generated predictive score can better aid spine surgeons assess risk and enhance justification for the use of BMP-2 during surgical intervention for adult spinal deformity. FDA DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices or drugs.
Copyright